Trials / Completed
CompletedNCT00808769
Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zegerid® | capsule(20 mg omeprazole/sodium bicarbonate), single dose |
| DRUG | Prilosec OTC® | Omeprazole-magnesium 20.6 mg, tablet, single dose |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-12-16
- Last updated
- 2015-06-01
- Results posted
- 2011-04-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00808769. Inclusion in this directory is not an endorsement.